Uncontrolled use of artemisinin leading to drug-resistant malaria

December 01, 2005

Scientists have found evidence of resistance to artemisinin malaria drugs in French Guiana and Senegal, reporting their findings in this week's issue of The Lancet. This decreased sensitivity may pave the way to treatment failures in these countries, state the authors.

The World Health Organization (WHO) recommends combination drug therapy, with formulations containing an artemisinin compound, for the first-line treatment of multi-drug resistant Plasmodium falciparum malaria.

Ronan Jambou, Eric Legrand, and colleagues from the Pasteur Institute Network tested blood samples from 530 patients from 3 countries (Cambodia, French Guiana, and Senegal), which have different patterns of artemisinin use. They measured the response to drugs in common use in each country. The investigators found that some samples from French Guiana and Senegal, where use of artemisinin is uncontrolled, were resistant to artemisinin. The samples from Cambodia, which has controlled use of arteminsinin, did not show this loss of sensitivity. The researchers also found that the loss of sensitivity was associated with mutations in the gene (SERCA-type Pftpase6) thought to be the target of artemisinin derivatives.

Dr Jambou concludes: "All resistant isolates came from areas with uncontrolled use of artemisinin derivatives. This rise in resistance indicates the need for increased vigilance and a coordinated rapid deployment of drug combinations."

In an accompanying Comment Patrick Duffy (Seattle Biomedical Research Institute, Washington, USA) and Carol Sibley (University of Washington, USA) state: "Jambou and colleagues' paper is a wake-up call; resistance to artemisinins may indeed be selected by uncontrolled use of artemisinins as monotherapy or in conjunction with ineffective partners."
-end-
Contact: Dr R Jambou, Unité d'immunologie, Institut Pasteur de Dakar, PO Box 220, Dakar, Senegal. T) +221 839 92 43 rjambou@pasteur.sn

Comment: Dr Patrick E Duffy, Malaria Antigen Discovery Program, Seattle Biomedical Research Institute, 307 Westlake Avenue North, Suite 500, Seattle, WA 98109, USA. T) 206-256-7311, patrick.duffy@sbri.org

Lancet

Related Drugs Articles from Brightsurf:

The danger of Z-drugs for dementia patients
Strong sleeping pills known as 'Z-drugs' are linked with an increased risk of falls, fractures and stroke among people with dementia, according to new research.

Wallflowers could lead to new drugs
Plant-derived chemicals called cardenolides - like digitoxin - have long been used to treat heart disease, and have shown potential as cancer therapies.

Bristol pioneers use of VR for designing new drugs
Researchers at the University of Bristol are pioneering the use of virtual reality (VR) as a tool to design the next generation of drug treatments.

Towards better anti-cancer drugs
The Bayreuth biochemist Dr. Claus-D. Kuhn and his research team have deciphered how the important human oncogene CDK8 is activated in cells of healthy individuals.

Separating drugs with MagLev
The composition of suspicious powders that may contain illicit drugs can be analyzed using a quick and simple method called magneto-Archimedes levitation (MagLev), according to a new study published in the journal Angewandte Chemie.

People are more likely to try drugs for the first time during the summer
American teenagers and adults are more likely to try illegal or recreational drugs for the first time in the summer, a new study shows.

Drugs used to enhance sexual experiences, especially in UK
Combining drugs with sex is common regardless of gender or sexual orientation, reveals new research by UCL and the Global Drug Survey into global trends of substance-linked sex.

Promising new drugs for old pathogen Mtb
UConn researchers are targeting a metabolic pathway, the dihydrofolate reductase pathway, crucial for amino acid synthesis to treat TB infections.

Can psychedelic drugs heal?
Many people think of psychedelics as relics from the hippie generation or something taken by ravers and music festival-goers, but they may one day be used to treat disorders ranging from social anxiety to depression, according to research presented at the annual convention of the American Psychological Association.

New uses for existing antiviral drugs
Broad-spectrum antiviral drugs work against a range of viral diseases, but developing them can be costly and time consuming.

Read More: Drugs News and Drugs Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.